Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Centessa Pharmaceuticals plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −3 vs. Q4 2021
- Shares held
- 74.6M
- +2.71M (+3.8%) vs. Q4 2021
- Total value
- $669.1M
- −$138.7M (−17.2%) vs. Q4 2021
- New holders
- 5
- 16 more added
- Sold out
- 8
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Hong Kong Ltd | 8 | $0 | 0.00% | +8 | New |
| State of Wyoming | 73 | $1.00K | 0.00% | +12+19.7% | Added |
| Kayne Anderson Rudnick Investment Management LLC | 80 | $1.00K | 0.00% | +80 | New |
| Global Retirement Partners, LLC | 350 | $2.00K | 0.00% | +350 | New |
| Citigroup Inc | 911 | $8.00K | 0.00% | −118−11.5% | Reduced |
| Adirondack Trust Co | 925 | $8.00K | 0.00% | +525+131.3% | Added |
| Advisor Group Holdings, Inc. | 1,015 | $9.00K | 0.00% | +265+35.3% | Added |
| Tower Research Capital LLC (TRC) | 1,245 | $11.0K | 0.00% | +315+33.9% | Added |
| JPMorgan Chase & Co | 4,716 | $42.0K | 0.00% | +207+4.6% | Added |
| FMR LLC | 10,300 | $92.0K | 0.00% | −84,000−89.1% | Reduced |
| Prelude Capital Management, LLC | 11,400 | $102.0K | 0.00% | +11,400 | New |
| Virtus ETF Advisers LLC | 13,969 | $125.0K | 0.06% | −829−5.6% | Reduced |
| Golden State Equity Partners | 15,970 | $143.0K | 0.07% | +2,100+15.1% | Added |
| Morgan Stanley | 21,612 | $194.0K | 0.00% | +7,527+53.4% | Added |
| TD Asset Management Inc | 33,252 | $298.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 44,177 | $396.0K | 0.00% | −35,068−44.3% | Reduced |
| Manufacturers Life Insurance Company, The | 57,421 | $518.5K | 0.00% | +57,421 | New |
| Affinity Asset Advisors, LLC | 65,282 | $586.0K | 0.23% | −353,862−84.4% | Reduced |
| BlackRock Inc. | 276,518 | $2.48M | 0.00% | −10,720−3.7% | Reduced |
| Citadel Advisors LLC | 304,426 | $2.73M | 0.00% | −35,639−10.5% | Reduced |
| Ensign Peak Advisors, Inc | 316,601 | $2.84M | 0.01% | −26,691−7.8% | Reduced |
| VR Adviser, LLC | 411,361 | $3.69M | 0.60% | −715,911−63.5% | Reduced |
| EcoR1 Capital, LLC | 454,545 | $4.08M | 0.13% | −427,631−48.5% | Reduced |
| Logos Global Management LP | 454,545 | $4.08M | 0.53% | 00.0% | Unchanged |
| American Century Companies Inc | 517,235 | $4.64M | 0.00% | +1120.0% | Added |
| Franklin Resources Inc | 616,903 | $5.53M | 0.00% | +41,365+7.2% | Added |
| Kynam Capital Management, LP | 669,100 | $6.00M | 1.95% | +430,059+179.9% | Added |
| Wellington Management Group LLP | 727,273 | $6.52M | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 882,633 | $7.92M | 0.13% | +81,497+10.2% | Added |
| Point72 Asset Management, L.P. | 907,000 | $8.14M | 0.04% | −190,908−17.4% | Reduced |
| Driehaus Capital Management LLC | 1,053,142 | $9.45M | 0.12% | −32,555−3.0% | Reduced |
| Baker Bros. Advisors LP | 1,127,273 | $10.1M | 0.06% | 00.0% | Unchanged |
| Boxer Capital, LLC | 1,251,137 | $11.3M | 0.58% | 00.0% | Unchanged |
| BVF Inc | 1,755,545 | $15.7M | 0.63% | +1,301,000+286.2% | Added |
| Samsara BioCapital, LLC | 1,884,096 | $16.9M | 4.27% | +424,403+29.1% | Added |
| Cormorant Asset Management, LP | 2,489,894 | $22.3M | 1.71% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,528,583 | $22.7M | 0.00% | +451,813+21.8% | Added |
| OUP Management Co., LLC | 2,937,615 | $26.4M | 20.06% | +595,724+25.4% | Added |
| Ra Capital Management, L.P. | 3,577,094 | $32.1M | 0.70% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 3,931,818 | $35.3M | 20.51% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 5,617,819 | $50.4M | 0.02% | −125,578−2.2% | Reduced |
| General Atlantic LLC | 9,681,818 | $86.8M | 0.79% | 00.0% | Unchanged |
| Index Venture Life Associates VI Ltd | 9,961,789 | $89.4M | 100.00% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $179.1M | 48.51% | +1,839,265+10.1% | Added |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −22,200−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −10,426−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −8,884−100.0% | Sold out |
| Compagnie Lombard Odier SCmA | 0 | $0 | 0.00% | −5,820−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −632−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −496−100.0% | Sold out |